Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor
Section snippets
Acknowledgements
Supported by the National Health and Medical Research Council (Australia) of which P.M.B. is a Senior Principal Research Fellow. The support and advice of Drs. B. Jarrott, A.J. Lawrence and J.F. Mercer during this study was greatly appreciated.
References (25)
- et al.
Septal-preoptic unit responses to microelectrophoresis of cholecystokinin, gastrin, vasoactive intestinal peptide and secretin in the rat
Brain Res.
(1986) - et al.
Cholecystokinin-induced activity changes of dorsal lateral geniculate neurones in rats
Neuroscience
(1994) - et al.
Immunocytochemical localization of delta opioid receptors in mouse brain
J. Chem. Neuroanat.
(1995) - et al.
Biological actions of cholecystokinin
Peptides
(1994) - et al.
Immunogenic structure of the influenza virus hemagglutinin
Cell
(1982) - et al.
CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic location
Brain Res.
(1988) - et al.
Species differences in the localization of `peripheral' type cholecystokinin receptors in rodent brain
Neurosci. Lett.
(1987) - et al.
Binding sites for 125I-cholecystokinin in primate spinal cord are of the CCK-A subclass
Neurosci. Lett.
(1988) - et al.
Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260
Brain Res.
(1990) - et al.
Differential gene expression of CCKA and CCKB receptors in the rat brain
Mol. Cell. Neurosci.
(1993)
Two brain cholecystokinin receptors: implications for behavioral actions
Brain Res.
Immunohistochemical mapping of angiotensin type 2 (AT2) receptors in rat brain
Brain Res.
Cited by (64)
Neuroendocrine Control of Energy Stores
2015, Williams Textbook of EndocrinologyAcute effects on brain cholecystokinin-like concentration and anxiety-like behaviour in the female rat upon a single injection of 17β-estradiol
2014, Pharmacology Biochemistry and BehaviorCitation Excerpt :However, there are few if any studies that have satisfactorily addressed the involvement of CCK in these diseases in females. CCK acts through the G-coupled CCK receptor 1 (CCK1-R) and CCK 2 receptor (CCK2-R, (IU-PHAR Classification Monograph, http://www.iuphar-db.org) (Beinfeld et al., 1981; Mercer and Beart, 1997; Mercer et al., 2000) and the anxiogenic properties have been shown to be regulated mainly through CCK2-R. Thus, Fekete et al. (1981) reported that anxiety and fear were aroused by means of injecting CCK-8 into the central nucleus of amygdala in rats, an effect that was found to be blocked by CCK2-R antagonists (Rotzinger and Vaccarino, 2003). CCK1-R on the other hand, seems rather to be involved in anxiolysis (Cohen et al., 2004).
Neuroendocrine Control of Energy Stores
2011, Williams Textbook of Endocrinology, Twelfth EditionCCK as a modulator of cardiovascular function
2009, Journal of Chemical NeuroanatomyCircadian rhythm drives the responsiveness of leptin-mediated hypothalamic pathway of cholecystokinin-8
2008, Neuroscience Letters